(2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione

C38H51F3N6O3 — CID 70888861

IUPAC(2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione
SMILESCNc1c(C)cc(C[C@@H](CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCCCC3)CC2)cc1C(F)(F)F
InChIInChI=1S/C38H51F3N6O3/c1-26-22-27(24-32(35(26)42-2)38(39,40)41)23-29(36(49)46-19-11-30(12-20-46)44-15-6-3-7-16-44)25-34(48)45-17-13-31(14-18-45)47-21-10-28-8-4-5-9-33(28)43-37(47)50/h4-5,8-9,22,24,29-31,42H,3,6-7,10-21,23,25H2,1-2H3,(H,43,50)/t29-/m0/s1
InChIKeyNEROMVROTYJERJ-LJAQVGFWSA-N
MW696.86 g/mol
LogP6.16
Rot. Bonds8

About (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione

(2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione (PubChem CID 70888861) has the molecular formula C38H51F3N6O3 and a molecular weight of 696.86 g/mol. Its IUPAC name is (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione.

Molecular Properties

Compound Name(2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione
PubChem CID70888861
Molecular FormulaC38H51F3N6O3
Molecular Weight696.86 g/mol
Exact Mass696.40
IUPAC Name(2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione
SMILESCNc1c(C)cc(C[C@@H](CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCCCC3)CC2)cc1C(F)(F)F
InChIInChI=1S/C38H51F3N6O3/c1-26-22-27(24-32(35(26)42-2)38(39,40)41)23-29(36(49)46-19-11-30(12-20-46)44-15-6-3-7-16-44)25-34(48)45-17-13-31(14-18-45)47-21-10-28-8-4-5-9-33(28)43-37(47)50/h4-5,8-9,22,24,29-31,42H,3,6-7,10-21,23,25H2,1-2H3,(H,43,50)/t29-/m0/s1
InChIKeyNEROMVROTYJERJ-LJAQVGFWSA-N
XLogP6.16
TPSA88.23 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds8
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500696.86
LogP ≤ 56.16
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione?
The IUPAC name of (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione (CID 70888861) is (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione.
What is the SMILES notation for (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione?
The canonical SMILES for (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione is CNc1c(C)cc(C[C@@H](CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)C(=O)N2CCC(N3CCCCC3)CC2)cc1C(F)(F)F.
What is the InChIKey of (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione?
The InChIKey is NEROMVROTYJERJ-LJAQVGFWSA-N. The full InChI is InChI=1S/C38H51F3N6O3/c1-26-22-27(24-32(35(26)42-2)38(39,40)41)23-29(36(49)46-19-11-30(12-20-46)44-15-6-3-7-16-44)25-34(48)45-17-13-31(14-18-45)47-21-10-28-8-4-5-9-33(28)43-37(47)50/h4-5,8-9,22,24,29-31,42H,3,6-7,10-21,23,25H2,1-2H3,(H,43,50)/t29-/m0/s1.
What are the key properties of (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione?
(2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione has a molecular weight of 696.86 g/mol, XLogP of 6.16, 8 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[[3-methyl-4-(methylamino)-5-(trifluoromethyl)phenyl]methyl]-4-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione is sourced from PubChem (CID 70888861), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).